Option chain shows key data for Murano Global Investments's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Murano Global Investments.

Murano Global Investments (NASDAQ:MRNOW) Stock, Option Chain

Murano Global Investments PLC is a real estate company that owns, develops, and invests in hotel, resort, and commercial properties throughout Mexico. Its portfolio includes the Andaz and Mondrian Hotels in Mexico City and Vivid Hotel Grand Island. The revenues are derived from the products and services provided to our customers such as Room rentals, Food and beverage, Private events, Spa services, and Other services.

Murano Global Investments PLC

Joby Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.20) by 70 percent. This is a 100 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $55.000 thousand which beat the analyst consensus estimate of $45.800 thousand by 20.09 percent. This is a 94.67 percent decrease over sales of $1.032 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

JOBY

Joby Aviation Q4 2024 GAAP EPS $(0.34) Misses $(0.20) Estimate, Sales $55.000K Beat $45.800K Estimate

KROS

Keros Therapeutics Q4 EPS $(1.14) Misses $(0.96) Estimate, Sales $3.04M Miss $15.42M Estimate

Contracts

GOOG

Amdocs Announces An Initiative To Transform How Telecommunications Companies Operate, Maintain, And Optimize Critical 5G Network Ecosystems With AI Using Google Cloud's Vertex AI And Bigquery

IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.21) by 342.86 percent. This is a 365 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $11.71 million which beat the analyst consensus estimate of $9.93 million by 17.91 percent. This is a 91.78 percent increase over sales of $6.11 million the same period last year.

IONQ

IonQ Q4 EPS $(0.93) Misses $(0.21) Estimate, Sales $11.71M Beat $9.93M Estimate

Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.41 by 9.76 percent. This is a 10 percent decrease over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $879.842 million which beat the analyst consensus estimate of $868.929 million by 1.26 percent. This is a 11.40 percent increase over sales of $789.805 million the same period last year.

PSTG

Pure Storage Q4 2025 Adj. EPS $0.45 Beats $0.41 Estimate, Sales $879.842M Beat $868.929M Estimate

Alector (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>) reported quarterly losses of $(0.02) per share. This is a 95.92 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $54.240 million which beat the analyst consensus estimate of $16.621 million by 226.33 percent. This is a 257.08 percent increase over sales of $15.190 million the same period last year.

ALEC

Alector Q4 2024 GAAP EPS $(0.02) Up From $(0.49) YoY, Sales $54.240M Beat $16.621M Estimate

APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) reported quarterly earnings of $0.79 per share which missed the analyst consensus estimate of $0.97 by 18.56 percent. This is a 31.3 percent decrease over earnings of $1.15 per share from the same period last year.

APA Q4 2024 Adj. EPS $0.79 Misses $0.97 Estimate

Theravance Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBPH#NASDAQ">TBPH</a>) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.21) by 76.19 percent. This is a 70.59 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $18.75 million which beat the analyst consensus estimate of $17.09 million by 9.73 percent. This is a 6.77 percent increase over sales of $17.57 million the same period last year.

TBPH

Theravance Biopharma Q4 Adj EPS $(0.05) Beats $(0.21) Estimate, Sales $18.75M Beat $17.09M Estimate

Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has corrected its upcoming Q4-Year End earnings call to March 4, 2025.

Events

PLUG

Plug Power Corrects Date For Q4-Year End 2024 Earnings Call To March 4, 2025

Guidance

Sweetgreen Sees Q1 Revenue $163M-$166M Vs $178.869M Est.

Kennedy-Wilson Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KW#NYSE">KW</a>) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.51) by 147.06 percent. This is a 113.48 percent increase over losses of $(1.78) per share from the same period last year. The company reported quarterly sales of $135.50 million which beat the analyst consensus estimate of $100.74 million by 34.50 percent. This is a 3.28 percent decrease over sales of $140.10 million the same period last year.

Kennedy-Wilson Holdings Q4 EPS $0.24 Beats $(0.51) Estimate, Sales $135.50M Beat $100.74M Estimate

Sweetgreen Sees FY25 Revenue $760M-$780M Vs $790.403M Est.

CrossAmerica Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAPL#NYSE">CAPL</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.04 by 950 percent. This is unchanged from the same period last year. The company reported quarterly sales of $944.22 million which missed the analyst consensus estimate of $1.21 billion by 21.88 percent. This is a 6.97 percent decrease over sales of $1.01 billion the same period last year.

CAPL

CrossAmerica Partners Q4 EPS $0.42 Beats $0.04 Estimate, Sales $944.22M Miss $1.21B Estimate

WIIM

AMBA

Ambarella shares are trading higher after the company reported better-than-expected Q4 sales results.

Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 4.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $160.900 which missed the analyst consensus estimate of $162.653 million by 100.00 percent. This is a 100.00 percent decrease over sales of $153.026 million the same period last year.

Sweetgreen Q4 2024 GAAP EPS $(0.25) Misses $(0.21) Estimate, Sales $160.900 Miss $162.653M Estimate

ZoomInfo Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) shares traded higher on Wednesday after the company reported 2024 fiscal-year fourth-quarter earnings on Tuesday <a href="https://www.benzinga.com//node/43960862">after the market closed</a>.
The Details: ZoomInfo reported adjusted earnings per share of 26 cents, beating the analyst estimates of 22 cents. In addition, the company reported sales of $309.10 million, beating the analyst estimate of $297.64, but representing a 2% decrease year-over-year.
Furthermore, ZoomInfo reported cash flow from operations of $369.4 million and adjusted operating income margin of 35%. The company also said it repurchased $562.3 million worth of stock or 46,801,742 shares throughout the fourth quarter.
&nbsp;&#8220;Our AI innovation and commitment to customer success helped us improve financial performance faster than expected, with strength continuing into 2025. With our operational improvements taking hold, we are delivering better-than-expected revenue, profitability, and free cash flow,&#8221; said Henry Schuck, ZoomInfo founder and CEO.&nbsp;
The company released guidance for the 2025 fiscal year first quarter. It sees revenue from $294 million to $297 million, versus the analyst estimate of $292.40 million and expects adjusted earnings per share from 22 cents to 23 cents, versus the analyst estimate of 22 cents.
Analyst Changes: Following the earnings report, multiple analysts issued <a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43986344/zoominfo-sees-stock-surge-as-analysts-spot-signs-of-turnaround-amid-upmarket-growth">price target adjustments</a>.
<ul>
<li>Canaccord Genuity analyst David Hynes maintained a Buy rating on ZoomInfo and raised the price target from&nbsp;$14&nbsp;to&nbsp;$15.</li>
<li>Morgan Stanley analyst Elizabeth Porter maintained an Equal-Weight rating on ZoomInfo and raised the price target from&nbsp;$11&nbsp;to&nbsp;$13.</li>
<li>Wells Fargo analyst Michael Turrin maintained an Equal-Weight rating on ZoomInfo and raised the price target from $11 to $12.</li>
</ul>
ZI Price Action: ZoomInfo stock closed 23.08% higher at $11.82, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
See Also: • <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43986397/axon-129-billion-market-opportunity-in-focus-analyst-sees-strong-product-innovation">Axon&#8217;s $129 Billion Market Opportunity In Focus: Analyst Sees Strong Product Innovation And More</a>
Image: This illustration was generated using artificial intelligence via Midjourney.

Movers

What's Going On With ZoomInfo Stock Wednesday?

TNDM

Tandem Diabetes shares are trading lower after the company issued FY25 revenue guidance below estimates.

FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) reported quarterly earnings of $0.61 per share which missed the analyst consensus estimate of $0.70 by 12.86 percent. This is a 1.61 percent decrease over earnings of $0.62 per share from the same period last year.

FirstEnergy Q4 2024 Adj. EPS $0.61 Misses $0.70 Estimate

Tandem Diabetes Care Sees Q1 Revenue $219M-$224M Vs 221.593M Est.

Tandem Diabetes Care Sees FY25 Revenue $997M-$1.007B Vs $1.008B Est.

Press Releases

Murano Global Investments Plc. Announces a New Share Repurchase Program

Murano Global Investments to Ring NASDAQ Opening Bell in Celebration of Recent Public Listing and Opening of Hyatt Vivid Grand Island Cancun

Murano Exploring Cruise Port Development in Baja California, Mexico

IPOs

Murano Announces Closing of U.S.$300 Million Offering of Senior Secured Notes

MRNO

MRNOW

Avalon Globocare

American Realty Investors, Inc. Common Stock

American Realty Investors

CKX Lands

FRP Holdings

New Concept Energy

The Intergroup Corporation - Common Stock

Intergroup

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of Common Stock)

IRSA Inversiones y

Kennedy-Wilson Holdings Inc. Common Stock

Kennedy-Wilson Holdings

LandBridge Company LLC Class A Shares Representing Limited Liability Company Interests

LandBridge

Logistic Properties of the Americas Ordinary Shares

Logistic Properties

Maui Land & Pineapple Company, Inc. Common Stock

Maui Land & Pineapple Co

Murano Global Investments

American Strategic Investment Co. Class A Common Stock

American Strategic

Belpointe PREP

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Reitar Logtech Holdings Limited - Ordinary shares

Reitar Logtech Holdings

Seaport Entertainment Group Inc. Common Stock

Seaport Entertainment

Seritage Growth Properties Class A Common Stock

Seritage Growth Props

Transcontinental Realty Investors, Inc. Common Stock

Transcontinental Realty

Corporacion Inmobiliaria Vesta, S.A.B de C.V. American Depositary Shares, each representing ten (10) Common Shares

Comments

Murano Global Investments

Murano Global Investments (MRNOW) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga